These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
156 related articles for article (PubMed ID: 28544435)
1. Solid Renal Masses in Transplanted Allograft Kidneys: A Closer Look at the Epidemiology and Management. Griffith JJ; Amin KA; Waingankar N; Lerner SM; Delaney V; Ames SA; Badani K; Palese MA; Mehrazin R Am J Transplant; 2017 Nov; 17(11):2775-2781. PubMed ID: 28544435 [TBL] [Abstract][Full Text] [Related]
2. Management of renal masses in transplant allografts at an Australian kidney-pancreas transplant unit. Su MZ; Campbell NA; Lau HM Transplantation; 2014 Mar; 97(6):654-9. PubMed ID: 24212503 [TBL] [Abstract][Full Text] [Related]
3. Treatment options for renal cell carcinoma in renal allografts: a case series from a single institution. Swords DC; Al-Geizawi SM; Farney AC; Rogers J; Burkart JM; Assimos DG; Stratta RJ Clin Transplant; 2013; 27(2):E199-205. PubMed ID: 23419131 [TBL] [Abstract][Full Text] [Related]
4. Oncocytoma managed by active surveillance in a transplant allograft kidney: a case report. Pagano D; di Francesco F; Rosa L; Nwaiwu CA; Li Petri S; Gruttadauria S World J Surg Oncol; 2018 Jul; 16(1):123. PubMed ID: 29966524 [TBL] [Abstract][Full Text] [Related]
6. Focal Ablative Therapy for Renal Cell Carcinoma in Transplant Allograft Kidneys. Gul ZG; Griffith JJ; Welch C; Fischman A; Palese MA; Badani KK; Mehrazin R Urology; 2019 Mar; 125():118-122. PubMed ID: 30552936 [TBL] [Abstract][Full Text] [Related]
7. Systematic review of ablative therapy for the treatment of renal allograft neoplasms. Favi E; Raison N; Ambrogi F; Delbue S; Clementi MC; Lamperti L; Perego M; Bischeri M; Ferraresso M World J Clin Cases; 2019 Sep; 7(17):2487-2504. PubMed ID: 31559284 [TBL] [Abstract][Full Text] [Related]
8. De novo concurrent papillary renal cell carcinoma and angiomyolipoma in a kidney allograft: evidence of donor origin. Rotman S; Déruaz C; Venetz JP; Chaubert P; Benhattar J; Meuwly JY; Jichlinski P; Guillou L; Moll S; Pascual M; Lemoine R Hum Pathol; 2006 Apr; 37(4):481-7. PubMed ID: 16564925 [TBL] [Abstract][Full Text] [Related]
10. Noninvasive therapy of incidental de novo renal cell carcinoma in a kidney allograft 12 years after transplantation: report of a case and review of literature. Matevossian E; Novotny A; Vogelsang B; Mehler J; Stangl M; Thorban S; Dobritz M Transplant Proc; 2008 May; 40(4):915-7. PubMed ID: 18555077 [TBL] [Abstract][Full Text] [Related]
11. A Rare Case of Donor-Derived Renal Cell Carcinoma in a Kidney Transplant Recipient. Sebastian W; Omar KO; Anees R; Nagaraju S; Chaitanya M Am J Case Rep; 2024 Mar; 25():e941214. PubMed ID: 38442088 [TBL] [Abstract][Full Text] [Related]
12. Detection and management of renal cell carcinoma in the renal allograft. Végső G; Toronyi É; Deák PÁ; Doros A; Langer RM Int Urol Nephrol; 2013 Feb; 45(1):93-8. PubMed ID: 22941752 [TBL] [Abstract][Full Text] [Related]
13. Renal cell carcinoma of the native kidney: a frequent tumor after kidney transplantation with favorable prognosis in case of early diagnosis. Végsö G; Toronyi E; Hajdu M; Piros L; Görög D; Deák PA; Doros A; Péter A; Langer RM Transplant Proc; 2011 May; 43(4):1261-3. PubMed ID: 21620106 [TBL] [Abstract][Full Text] [Related]
14. Clear cell papillary renal cell carcinoma in a transplant kidney. Harriman D; Mikhailov A; Rogers J; Stratta R; Farney A Can J Urol; 2019 Jun; 26(3):9794-9798. PubMed ID: 31180312 [TBL] [Abstract][Full Text] [Related]
15. Comparison of partial nephrectomy and percutaneous ablation for cT1 renal masses. Thompson RH; Atwell T; Schmit G; Lohse CM; Kurup AN; Weisbrod A; Psutka SP; Stewart SB; Callstrom MR; Cheville JC; Boorjian SA; Leibovich BC Eur Urol; 2015 Feb; 67(2):252-9. PubMed ID: 25108580 [TBL] [Abstract][Full Text] [Related]